EC Healthcare Signs Sustainability-Linked Syndicated Facility, A Ground-breaking Achievement in Hong Kong Healthcare Industry
HONG KONG, May 10, 2023 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce the signing of its first syndicated sustainability-linked loan ("SLL") with a consortium of 5 banks. The SLL was upsized from an initial target of HK$ 700 million to HK$ 1,000 million, demonstrating relationship banks' strong support for the Group and reflecting their confidence in the growth potential of the healthcare industry.
This syndicated SLL, comprising of a revolving credit and term loan, is the first-of-its-kind for a healthcare services provider in Hong Kong. It further enhances the Group's status as a leading industry pioneer and reaffirms the importance of sustainability in the Group's future growth strategy. The proceeds will be used to support the group's expansion plans and working capital needs.
The Mandated Lead Arrangers, Bookrunners and Sustainability Coordinators include The Bank of East Asia, Ltd, The Hongkong & Shanghai Banking Corporation Ltd, and DBS Bank Ltd.
SGS Hong Kong Limited, a leading sustainability consultancy firm, acted as ESG consultant on the SLL to ensure that the new environmental and social targets are aligned with the latest internationally recognized market standards.
Ms. Ada Wong, Executive Director, Chief Strategy Officer & Chief Investment Officer of EC Healthcare said, "This SLL marks another important milestone in the Group's sustainability journey. This transaction recognizes our ongoing ESG efforts and also represents a strong endorsement from the banking community on the Group's business strategy and future growth ambitions. Additionally, the successful arrangement of SLLs in two consecutive years deepens our leadership in terms of sustainable financing in the healthcare sector and reinforces our commitment to sustainability in the long-term."
About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.
The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, an advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center EC EYE and EC Veterinary Hospital and Imaging Center.
*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021
For further information, please contact: iPR Ogilvy Limited Callis Lau / Lorraine Luk / Tim Tin Tel: (852) 2136 6952 / 2169 0467 / 3920 7654 Fax: (852) 3170 6606 Email: ech@iprogilvy.com
Source: EC Healthcare Sectors: Healthcare & Pharm, Clinical Trials
Copyright ©2023 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 PHOENIX HARMONIA, A Very Large LPG/Ammonia Carrier Constructed by Namura Shipbuilding, Enters into Service Sep 29, 2023 17:11 JST
|  Stylish, Sporty, Spacious and All-Electric: Honda Prologue SUV Available Early Next Year with Anticipated EPA Range Rating of 300 Miles Sep 29, 2023 14:31 JST
|  MHI Thermal Systems Scores Highly Again with Air-Conditioners for Australia and New Zealand Markets Sep 29, 2023 11:51 JST
|  World's Best Honda Motorcycle Technician to be Determined at Inaugural Honda Global Motorcycle Technician Contest Sep 29, 2023 11:05 JST
|  Eisai Launches New "Innovation" Page on Corporate Website Sep 28, 2023 17:05 JST
|  Tokio Marine Nichido and Eisai Co-Develop Industry's First "Dementia Care Support Insurance" Sep 28, 2023 14:49 JST
|  NEC sets record for 800 Gbps long-distance transmission over an optical submarine cable system Sep 28, 2023 13:56 JST
|  JCB launches a special offer program in Hokkaido for inbound tourist to Japan Sep 28, 2023 13:00 JST
|  OREX Announces OREX Open RAN Service Lineup Sep 27, 2023 14:33 JST
|  Toyota and Woven by Toyota to Strengthen Ties Toward Accelerating Software Implementation Sep 27, 2023 13:11 JST
|  Fujitsu delivers O-RAN ALLIANCE-compliant 5G virtualized RAN solution for NTT DOCOMO's 5G commercial network services Sep 27, 2023 10:32 JST
|  DOCOMO to Transfer Ownership of 1,552 Telecommunication Towers to JTOWER to Promote Infrastructure Sharing Sep 27, 2023 10:03 JST
|  MHI and ZutaCore Join Forces in a Strategic Alliance, Paving the Way for a Zero-emission Data Industry Sep 27, 2023 09:00 JST
|  Overview of Honda Exhibits at the JAPAN MOBILITY SHOW 2023 Sep 26, 2023 17:25 JST
|  Fujitsu launches new technologies to protect conversational AI from hallucinations and adversarial attacks Sep 26, 2023 11:02 JST
|  Fujitsu and iSurgery launch bone health promotion project in Japan with Jikei University School of Medicine aiming for early detection of osteoporosis Sep 26, 2023 10:20 JST
|  Mitsubishi Motors to Showcase a Fulfilling Mobility Lifestyle that Awakens Drivers' Adventurous Spirit at the Japan Mobility Show 2023 Sep 25, 2023 17:50 JST
|  "LEQEMBI Intravenous Infusion" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan Sep 25, 2023 15:17 JST
| Value Research Center (VRC) at SSUNGA78: 'How Purpose, Value, and Impact will Drive a Sustainable Post-SDG Future' Sep 25, 2023 03:00 JST
|  TOYOTA GAZOO Racing returns to South American roads Sep 22, 2023 18:26 JST
|
More Latest Release >>
|